Company intelligence / Profile preview

Myeloma Investment Fund

Norwalk, Connecticut, United States

Ownership: Private
Development stage: Other

Overview

Myeloma Investment Fund is an active venture philanthropy arm of the Multiple Myeloma Research Foundation. It has invested in at least 12 companies pursuing 14 myeloma programs, supporting development from discovery through early clinical trials. The goal is to accelerate transformative therapies for multiple myeloma by providing capital and strategic support to innovative biotech startups and established firms alike. All financial returns are reinvested into the evergreen model for future investments.

Therapeutic areas: Oncology
Modalities: Cell therapyMonoclonal antibodySmall moleculeRNA therapy
Industry: Investors

Partnerships

Opna BioIndapta TherapeuticsEnvisagenicsNammi TherapeuticsReverb TherapeuticsTRIO Pharmaceuticals

Beyond the preview

Go deeper on Myeloma Investment Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myeloma Investment Fund.

Explore the full profile